Skip to content

SPRY - ARS Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

ARS Pharmaceuticals, Inc

SPRY · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SPRYARS Pharmaceuticals, Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $14.97
52-wk low: $4.91
Prev close: $10.45
Mkt cap: $634.5M
Beta: 0.97
P/S: 5.4x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$121.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$19.2M
position
BC
Baron Capital

Earnings

Reported May 15, 2026

Earnings came in 15.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -184.2%
Market cap: $634M

Valuation

P/S5.43
P/B50.15

Quality

Operating margin-182.6%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SPRY
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $634.47M
Beta: 0.97

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

50.1x

Profit margin

-184.2%

Op margin

-182.6%

ROE

-210.3%

Q1 2026 13F

$10.2M

position

DL

Daniel Loeb

Q2 2026 13F

$8.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SPRY

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.61-15.1%

-$0.53 expected

Next report

What the street expects next

EPS expected

-$0.30

-$0.38 to -$0.24

Revenue expected

$44.8M

4 analysts

Last 30 days

2up0down

Analysts raising estimates

Estimate drift

0.03

Change in 30 days

-210.3%

ROA-48.0%

Growth

Beta0.97